0 items USD 0.00Search
Your search for "global markets direct santhera pharmaceuticals holding ag product pipeline review 2015" gave back 83406 results.
Summary Publisher estimates that the Primary Progressive Multiple Sclerosis Treatment market size will grow from xxx Million USD in 2020 to xxxx...
Catalog:
HYR
June 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Primary Progressive Multiple Sclerosis Treatment market size will grow from xxx Million USD in 2020 to xxxx...
Catalog:
HYR
January 2021
Price: USD 2,000.00
Highlights The global Primary Progressive Multiple Sclerosis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Primary Progressive Multiple Sclerosis Treatment Market The global Primary Progressive Multiple Sclerosis...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Summary The global Primary Progressive Multiple Sclerosis Treatment market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective...
Catalog:
HYR
September 2021
Price: USD 1,800.00
The “Constrained Peptide Drugs Industry Forecast” looks at past sales and reviews total world Constrained Peptide Drugs sales in 2022, providing a...
Catalog:
LPI
February 2023
Price: USD 3,660.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Constrained Peptide Drugs market will undergo major...
Catalog:
Arsta
June 2022
Price: USD 3,360.00
Highlights The global Constrained Peptide Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Constrained Peptide Drugs Market The global Constrained Peptide Drugs market is projected to grow from US$...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Duchenne muscular dystrophy, sometimes shortened to DMD or just Duchenne, is a rare genetic disease. It predominantly affects males, but, in rare...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Duchenne Muscular Dystrophy (DMD) Therapeutics market size was valued at USD 1367.7 million in 2023 and is forecast to a readjusted size...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Duchenne muscular dystrophy, sometimes shortened to DMD or just Duchenne, is a rare genetic disease. It predominantly affects males, but, in rare...
Catalog:
LPI
February 2023
Price: USD 3,660.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Constrained Peptide Drugs market will undergo major...
Catalog:
Arsta
June 2022
Price: USD 3,360.00
The global Duchenne Muscular Dystrophy (DMD) Therapeutics market size was valued at US$ 1300.3 million in 2023. With growing demand in downstream...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Duchenne muscular dystrophy, sometimes shortened to DMD or just Duchenne, is a rare genetic disease. It predominantly affects males, but, in rare...
Catalog:
GIR
April 2023
Price: USD 3,480.00
